| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Forte Biosciences, Inc. | President and Chief Scientific Officer | Common Stock | 93.4K | $76.8K | $0.82 | Jan 1, 2024 | Direct |
| Forte Biosciences, Inc. | President and Chief Scientific Officer | Restricted Stock Units | 90K | $74K | $0.82 | Jan 1, 2024 | Direct |
| Metacrine, Inc. | Chief Medical Officer | Common Stock | 3.29K | $1.55K | $0.47 | May 20, 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| FBRX | Forte Biosciences, Inc. | Jan 1, 2024 | 3 | -$2.53K | 4 | Jan 3, 2024 | President and Chief Scientific Officer |
| FBRX | Forte Biosciences, Inc. | Oct 1, 2023 | 3 | -$1.72K | 4 | Oct 3, 2023 | President and Chief Scientific Officer |
| FBRX | Forte Biosciences, Inc. | Jul 31, 2023 | 1 | $75K | 4 | Aug 2, 2023 | President and Chief Scientific Officer |
| FBRX | Forte Biosciences, Inc. | Jul 1, 2023 | 3 | -$2.7K | 4 | Jul 5, 2023 | President and Chief Scientific Officer |
| FBRX | Forte Biosciences, Inc. | Apr 1, 2023 | 3 | -$2.62K | 4 | Apr 4, 2023 | President and Chief Scientific Officer |
| FBRX | Forte Biosciences, Inc. | Feb 25, 2023 | 1 | $0 | 4 | Feb 27, 2023 | President and Chief Scientific Officer |
| FBRX | Forte Biosciences, Inc. | Jun 7, 2022 | 1 | $0 | 4 | Jun 8, 2022 | President and Chief Scientific Officer |
| FBRX | Forte Biosciences, Inc. | Jun 7, 2022 | 0 | $0 | 3 | Jun 8, 2022 | President and Chief Scientific Officer Exhibit 24 - Power of Attorney |
| MTCR | Metacrine, Inc. | May 20, 2021 | 1 | $11.8K | 4 | May 20, 2021 | Chief Medical Officer |